ATXS
Astria Therapeutics Inc.
$7.05
-$0.43(-5.75%)
52
Overall
--
Value
70
Tech
34
Quality
Market Cap
$410.28M
Volume
1.30M
52W Range
$3.56 - $12.88
Target Price
$29.33
EPS Estimates Overview
| Current Quarter | $-0.42 | Next Quarter | $-0.55 |
| Current Year | $-2.09 | Next Year | $-2.25 |
| QoQ Growth | -31.0% | YoY Growth | -7.7% |
| 3Y EPS CAGR | N/A | Target Price | $29.33 |
| Consensus | Buy | Upside | +316.0% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ATXS | $7.05 | -5.7% | 1.30M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Astria Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW